Novartis provides update on regulatory developments regarding its pending acquisitions of Hexal AG and Eon Labs
12-Apr-2005 -
Novartis announced that it has made submissions to European and US regulatory authorities seeking approval to acquire the generic pharmaceutical companies Hexal AG of Germany and Eon Labs, Inc. of the US. Novartis filed on April 4, 2005, for European Commission approval under the Merger Control ...
Germany
Novartis
regulatory approval